CN108175854A - 一种乙脑疫苗的冻干制剂 - Google Patents
一种乙脑疫苗的冻干制剂 Download PDFInfo
- Publication number
- CN108175854A CN108175854A CN201711456514.8A CN201711456514A CN108175854A CN 108175854 A CN108175854 A CN 108175854A CN 201711456514 A CN201711456514 A CN 201711456514A CN 108175854 A CN108175854 A CN 108175854A
- Authority
- CN
- China
- Prior art keywords
- vaccine
- preparation
- vaccinum encephalitidis
- encephalitidis epidemicae
- lyophilized preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711456514.8A CN108175854B (zh) | 2017-12-28 | 2017-12-28 | 一种乙脑疫苗的冻干制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711456514.8A CN108175854B (zh) | 2017-12-28 | 2017-12-28 | 一种乙脑疫苗的冻干制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108175854A true CN108175854A (zh) | 2018-06-19 |
CN108175854B CN108175854B (zh) | 2021-08-03 |
Family
ID=62548358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711456514.8A Active CN108175854B (zh) | 2017-12-28 | 2017-12-28 | 一种乙脑疫苗的冻干制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108175854B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109395074A (zh) * | 2018-12-21 | 2019-03-01 | 辽宁成大生物股份有限公司 | 一种乙型脑炎灭活疫苗冻干制剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003055256A (ja) * | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | 安定な血液凝固第xiii因子製剤 |
CN1548148A (zh) * | 2003-05-16 | 2004-11-24 | 珠海亿胜生物制药有限公司 | 一种重组人碱性成纤维细胞生长因子胶囊剂及其制备方法 |
-
2017
- 2017-12-28 CN CN201711456514.8A patent/CN108175854B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003055256A (ja) * | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | 安定な血液凝固第xiii因子製剤 |
CN1548148A (zh) * | 2003-05-16 | 2004-11-24 | 珠海亿胜生物制药有限公司 | 一种重组人碱性成纤维细胞生长因子胶囊剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
张晋等: "冻干乙型脑炎灭活疫苗(Vero细胞)非动物源性稳定剂的筛选", 《中国生物制品学杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109395074A (zh) * | 2018-12-21 | 2019-03-01 | 辽宁成大生物股份有限公司 | 一种乙型脑炎灭活疫苗冻干制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108175854B (zh) | 2021-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102657870B (zh) | 一种无明胶及人血蛋白成分的疫苗冻干保护剂 | |
AU2014212104B2 (en) | Immunogenic compositions comprising silicified virus and methods of use | |
WO2010124428A1 (zh) | 一种不含明胶的疫苗冻干保护剂及其制备方法 | |
CN105267971B (zh) | 一种不含明胶和人血白蛋白的疫苗冻干保护剂 | |
Nguyen et al. | Arthritogenic alphavirus vaccines: serogrouping versus cross-protection in mouse models | |
Zhao et al. | Chitosan nanovaccines as efficient carrier adjuvant system for IL-12 with enhanced protection against HBV | |
CN104548110A (zh) | 一种无明胶和人血白蛋白成分的腮苗冻保剂 | |
CN108175854A (zh) | 一种乙脑疫苗的冻干制剂 | |
CN102631672A (zh) | 一种冻干灭活乙型脑炎疫苗 | |
CN103656660B (zh) | 一种动物活疫苗耐热冻干保护剂、其制备方法及应用 | |
CN107184985B (zh) | 鸡新城疫活疫苗(Lasota株)的耐热冻干保护剂 | |
CN106668867B (zh) | 一种不含明胶和人血白蛋白的腮腺炎疫苗冻干保护剂 | |
CN108434106A (zh) | 一种狂犬病疫苗的冻干制剂 | |
CN101618213B (zh) | 麻疹腮腺炎乙型脑炎联合减毒活疫苗及其制备方法 | |
NZ235153A (en) | Stabilised alpha-interferon compositions | |
CN110420324B (zh) | 含兔葡萄球菌抗原的免疫原性组合物及其制备方法和应用 | |
CN114028551A (zh) | 猪瘟活疫苗耐热保护剂及其制备方法与应用 | |
CN103977414B (zh) | 一种冻干抗原活力稳定剂及其制备方法 | |
Ozawa | Studies on the replication of African horse-sickness virus in two different cell line cultures | |
Larke | Interferon: a changing picture | |
Tenbroeck et al. | Mustard inactivated rabies vaccine | |
CN109106948A (zh) | 一种口蹄疫抗原保护剂及其应用 | |
Baron et al. | A host defense role for a natural antiviral substance in the nervous system | |
RU2121364C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ЛИОФИЛИЗИРОВАННОГО ПРЕПАРАТА НА ОСНОВЕ РЕКОМБИНАНТНОГО α-2-ИНТЕРФЕРОНА ПРОТИВ ВИРУСНЫХ БОЛЕЗНЕЙ ПЛОТОЯДНЫХ | |
RU2380405C2 (ru) | Способ получения рекомбинантного альфа 16-интерферона человека и фармацевтическая композиция для лечения вирусных заболеваний на основе рекомбинантного альфа 16-интерферона человека |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181221 Address after: Room 305, Block G, Guangzhou International Business Incubator, No. 3 Lanyue Road, Science City, Luogang District, Guangzhou City, Guangdong Province Applicant after: Guangzhou Galaxy Sun Biological Products Co., Ltd. Address before: Room 306, 307 and 308, Block G, No. 3 Lanyue Road, Science City, Guangzhou High-tech Industrial Development Zone, Guangdong Province Applicant before: Guangzhou Rui Beisi Pharmaceutical Co. Ltd. Applicant before: Guangzhou Galaxy Sun Biological Products Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |